Morphological Macular Changes Under Brolucizumab Treatment for Neovascular Age-Related Macular Degeneration Refractory to Previous Anti-VEGF Treatment Compared with Treatment-Naive Eyes

PURPOSE: To evaluate the morphological macular changes and fluid dynamics under brolucizumab treatment in eyes refractory to previous anti–vascular endothelial growth factor (anti-VEGF) treatment for neovascular age-related macular degeneration (nAMD) compared with treatment-naive eyes. METHODS: Ret...

Descripción completa

Detalles Bibliográficos
Autores principales: William, Antony, Verma-Fuehring, Raoul, Kuehnel, Sophia, Schwabe, Dorothee, Kampik, Daniel, Goebel, Winfried, Hillenkamp, Jost
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008413/
https://www.ncbi.nlm.nih.gov/pubmed/36919033
http://dx.doi.org/10.2147/OPTH.S396304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008413/
https://www.ncbi.nlm.nih.gov/pubmed/36919033
http://dx.doi.org/10.2147/OPTH.S396304

Ejemplares similares